A front-line antiviral drug disappoints against worrisome monkeypox strainTecovirimat, approved in Europe for mpox, showed limited effectiveness in hastening recovery in human clinical trials.
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers ReportPaxlovid may benefit some long Covid patients, but results vary significantly and the underlying causes remain unclear.
New York's Preparations for a Bird Flu Pandemic Rely on a Single DrugNew York heavily relies on Tamiflu for bird flu treatment, missing out on the potentially more effective baloxavir marboxil.